Vivos (RDGL) Amortizatization of Intangibles (2010 - 2021)
Vivos (RDGL) reported Amortizatization of Intangibles of $28482.0 for Q1 2021, down 46.79% on a YoY basis from $53527.0 in Q1 2020, and down 46.79% sequentially from $53527.0 in Q1 2020.
Vivos (RDGL) Amortizatization of Intangibles (2010 - 2021) Analysis & Trends
Vivos (RDGL) has 12 years of Amortizatization of Intangibles data on file, last reported at $28482.0 in Q1 2021.
- For the quarter ending Q1 2021, Amortizatization of Intangibles fell 46.79% year-over-year to $28482.0; the trailing twelve-month figure through Jun 2021 stood at $28482.0 (down 82.44% YoY), and the FY2020 full-year result was $53527.0, down 60.06% from the prior year.
- Amortizatization of Intangibles fell to $28482.0 in Q1 2021, from $53527.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $564865.0 in Q1 2018 to a low of -$9.0 in Q4 2018.
- A 5-year average of $216508.2 and a median of $60296.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles sank 100.0% in 2018 and soared 4159600.0% in 2019, its largest moves.
- Tracing RDGL's Amortizatization of Intangibles over 5 years: stood at $549939.0 in 2017, then slumped by 100.0% to -$9.0 in 2018, then soared by 745266.67% to $67065.0 in 2019, then fell by 20.19% to $53527.0 in 2020, then slumped by 46.79% to $28482.0 in 2021.
- Business Quant data shows RDGL's Amortizatization of Intangibles at $28482.0 in Q1 2021, $53527.0 in Q1 2020, and $67065.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 28,482.00 |
| Mar 31, 2021 | 28,482.00 |
| Mar 31, 2020 | 53,527.00 |
| Mar 31, 2020 | 53,527.00 |
| Dec 31, 2019 | 67,065.00 |
| Dec 31, 2019 | 67,065.00 |
| Sep 30, 2019 | 41,595.00 |
| Sep 30, 2019 | 41,595.00 |
| Jun 30, 2019 | 18,668.00 |
| Jun 30, 2019 | 18,668.00 |
| Mar 31, 2019 | 6,706.00 |
| Mar 31, 2019 | 6,706.00 |
| Dec 31, 2018 | -9.00 |
| Dec 31, 2018 | -9.00 |
| Sep 30, 2018 | -1.00 |
| Sep 30, 2018 | -1.00 |
| Jun 30, 2018 | 227,073.00 |
| Jun 30, 2018 | 227,073.00 |
| Mar 31, 2018 | 564,865.00 |
| Mar 31, 2018 | 564,865.00 |